Neomonachus schauinslandi (Hawaiian monk seal): 110572155
Help
Entry
110572155 CDS
T08474
Symbol
NFKB1
Name
(RefSeq) nuclear factor NF-kappa-B p105 subunit isoform X1
KO
K02580
nuclear factor NF-kappa-B p105 subunit
Organism
nsu
Neomonachus schauinslandi (Hawaiian monk seal)
Pathway
nsu01523
Antifolate resistance
nsu04010
MAPK signaling pathway
nsu04014
Ras signaling pathway
nsu04024
cAMP signaling pathway
nsu04062
Chemokine signaling pathway
nsu04064
NF-kappa B signaling pathway
nsu04066
HIF-1 signaling pathway
nsu04071
Sphingolipid signaling pathway
nsu04151
PI3K-Akt signaling pathway
nsu04210
Apoptosis
nsu04211
Longevity regulating pathway
nsu04218
Cellular senescence
nsu04380
Osteoclast differentiation
nsu04613
Neutrophil extracellular trap formation
nsu04620
Toll-like receptor signaling pathway
nsu04621
NOD-like receptor signaling pathway
nsu04622
RIG-I-like receptor signaling pathway
nsu04623
Cytosolic DNA-sensing pathway
nsu04625
C-type lectin receptor signaling pathway
nsu04657
IL-17 signaling pathway
nsu04658
Th1 and Th2 cell differentiation
nsu04659
Th17 cell differentiation
nsu04660
T cell receptor signaling pathway
nsu04662
B cell receptor signaling pathway
nsu04668
TNF signaling pathway
nsu04722
Neurotrophin signaling pathway
nsu04917
Prolactin signaling pathway
nsu04920
Adipocytokine signaling pathway
nsu04926
Relaxin signaling pathway
nsu04931
Insulin resistance
nsu04932
Non-alcoholic fatty liver disease
nsu04933
AGE-RAGE signaling pathway in diabetic complications
nsu04936
Alcoholic liver disease
nsu05010
Alzheimer disease
nsu05022
Pathways of neurodegeneration - multiple diseases
nsu05030
Cocaine addiction
nsu05132
Salmonella infection
nsu05133
Pertussis
nsu05134
Legionellosis
nsu05135
Yersinia infection
nsu05140
Leishmaniasis
nsu05142
Chagas disease
nsu05145
Toxoplasmosis
nsu05146
Amoebiasis
nsu05152
Tuberculosis
nsu05160
Hepatitis C
nsu05161
Hepatitis B
nsu05162
Measles
nsu05163
Human cytomegalovirus infection
nsu05164
Influenza A
nsu05165
Human papillomavirus infection
nsu05166
Human T-cell leukemia virus 1 infection
nsu05167
Kaposi sarcoma-associated herpesvirus infection
nsu05168
Herpes simplex virus 1 infection
nsu05169
Epstein-Barr virus infection
nsu05170
Human immunodeficiency virus 1 infection
nsu05171
Coronavirus disease - COVID-19
nsu05200
Pathways in cancer
nsu05202
Transcriptional misregulation in cancer
nsu05203
Viral carcinogenesis
nsu05206
MicroRNAs in cancer
nsu05207
Chemical carcinogenesis - receptor activation
nsu05208
Chemical carcinogenesis - reactive oxygen species
nsu05212
Pancreatic cancer
nsu05215
Prostate cancer
nsu05220
Chronic myeloid leukemia
nsu05221
Acute myeloid leukemia
nsu05222
Small cell lung cancer
nsu05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
nsu05321
Inflammatory bowel disease
nsu05415
Diabetic cardiomyopathy
nsu05417
Lipid and atherosclerosis
nsu05418
Fluid shear stress and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
nsu00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
110572155 (NFKB1)
04014 Ras signaling pathway
110572155 (NFKB1)
04064 NF-kappa B signaling pathway
110572155 (NFKB1)
04668 TNF signaling pathway
110572155 (NFKB1)
04066 HIF-1 signaling pathway
110572155 (NFKB1)
04071 Sphingolipid signaling pathway
110572155 (NFKB1)
04024 cAMP signaling pathway
110572155 (NFKB1)
04151 PI3K-Akt signaling pathway
110572155 (NFKB1)
09140 Cellular Processes
09143 Cell growth and death
04210 Apoptosis
110572155 (NFKB1)
04218 Cellular senescence
110572155 (NFKB1)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
110572155 (NFKB1)
04620 Toll-like receptor signaling pathway
110572155 (NFKB1)
04621 NOD-like receptor signaling pathway
110572155 (NFKB1)
04622 RIG-I-like receptor signaling pathway
110572155 (NFKB1)
04623 Cytosolic DNA-sensing pathway
110572155 (NFKB1)
04625 C-type lectin receptor signaling pathway
110572155 (NFKB1)
04660 T cell receptor signaling pathway
110572155 (NFKB1)
04658 Th1 and Th2 cell differentiation
110572155 (NFKB1)
04659 Th17 cell differentiation
110572155 (NFKB1)
04657 IL-17 signaling pathway
110572155 (NFKB1)
04662 B cell receptor signaling pathway
110572155 (NFKB1)
04062 Chemokine signaling pathway
110572155 (NFKB1)
09152 Endocrine system
04920 Adipocytokine signaling pathway
110572155 (NFKB1)
04917 Prolactin signaling pathway
110572155 (NFKB1)
04926 Relaxin signaling pathway
110572155 (NFKB1)
09156 Nervous system
04722 Neurotrophin signaling pathway
110572155 (NFKB1)
09158 Development and regeneration
04380 Osteoclast differentiation
110572155 (NFKB1)
09149 Aging
04211 Longevity regulating pathway
110572155 (NFKB1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
110572155 (NFKB1)
05202 Transcriptional misregulation in cancer
110572155 (NFKB1)
05206 MicroRNAs in cancer
110572155 (NFKB1)
05207 Chemical carcinogenesis - receptor activation
110572155 (NFKB1)
05208 Chemical carcinogenesis - reactive oxygen species
110572155 (NFKB1)
05203 Viral carcinogenesis
110572155 (NFKB1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
110572155 (NFKB1)
09162 Cancer: specific types
05212 Pancreatic cancer
110572155 (NFKB1)
05221 Acute myeloid leukemia
110572155 (NFKB1)
05220 Chronic myeloid leukemia
110572155 (NFKB1)
05215 Prostate cancer
110572155 (NFKB1)
05222 Small cell lung cancer
110572155 (NFKB1)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
110572155 (NFKB1)
05170 Human immunodeficiency virus 1 infection
110572155 (NFKB1)
05161 Hepatitis B
110572155 (NFKB1)
05160 Hepatitis C
110572155 (NFKB1)
05171 Coronavirus disease - COVID-19
110572155 (NFKB1)
05164 Influenza A
110572155 (NFKB1)
05162 Measles
110572155 (NFKB1)
05168 Herpes simplex virus 1 infection
110572155 (NFKB1)
05163 Human cytomegalovirus infection
110572155 (NFKB1)
05167 Kaposi sarcoma-associated herpesvirus infection
110572155 (NFKB1)
05169 Epstein-Barr virus infection
110572155 (NFKB1)
05165 Human papillomavirus infection
110572155 (NFKB1)
09171 Infectious disease: bacterial
05132 Salmonella infection
110572155 (NFKB1)
05135 Yersinia infection
110572155 (NFKB1)
05133 Pertussis
110572155 (NFKB1)
05134 Legionellosis
110572155 (NFKB1)
05152 Tuberculosis
110572155 (NFKB1)
09174 Infectious disease: parasitic
05146 Amoebiasis
110572155 (NFKB1)
05145 Toxoplasmosis
110572155 (NFKB1)
05140 Leishmaniasis
110572155 (NFKB1)
05142 Chagas disease
110572155 (NFKB1)
09163 Immune disease
05321 Inflammatory bowel disease
110572155 (NFKB1)
09164 Neurodegenerative disease
05010 Alzheimer disease
110572155 (NFKB1)
05022 Pathways of neurodegeneration - multiple diseases
110572155 (NFKB1)
09165 Substance dependence
05030 Cocaine addiction
110572155 (NFKB1)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
110572155 (NFKB1)
05418 Fluid shear stress and atherosclerosis
110572155 (NFKB1)
05415 Diabetic cardiomyopathy
110572155 (NFKB1)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
110572155 (NFKB1)
04932 Non-alcoholic fatty liver disease
110572155 (NFKB1)
04931 Insulin resistance
110572155 (NFKB1)
04933 AGE-RAGE signaling pathway in diabetic complications
110572155 (NFKB1)
09176 Drug resistance: antineoplastic
01523 Antifolate resistance
110572155 (NFKB1)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
03000 Transcription factors [BR:
nsu03000
]
110572155 (NFKB1)
Transcription factors [BR:
nsu03000
]
Eukaryotic type
beta-Scaffold factors with minor groove contacts
RHR (Rel homology region) Rel/Ankyrin
110572155 (NFKB1)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
RHD_DNA_bind
RHD_dimer
Ank_2
Ank
Ank_4
Ank_3
Ank_5
Death
Motif
Other DBs
NCBI-GeneID:
110572155
NCBI-ProteinID:
XP_021536091
EnsemblRapid:
ENSNSCG00000014657
UniProt:
A0A2Y9GAP8
LinkDB
All DBs
Position
2:complement(119553576..119667831)
Genome browser
AA seq
986 aa
AA seq
DB search
MAEDDTYLGGHEQMFHLDPLTHTIFNPELFQPEMPLPTDGPYLQILEQPKQRGFRFRYVC
EGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDG
ICTVTAGPKDMVVGFANLGILHVTKKKVLETLEARMIEACTKGYNPGLLVHPDLAYLQAE
GGGDRQLTDREKEIIHQAAVQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYD
SKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGIWEGFGDFS
PTDVHRQFAIVFKTPKYKDVNITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQR
KRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGAAGSTGPGYSFPHYGFPTYGGITFHP
GTTKSNAGMKHGTIDTPSKNDSEGCGKSVDREAASLPGKVTEPAEQDKESSTGDDEVTLT
YTVGVKEENSRFQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGD
SVLHLAIIHLHAQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEAVVEDLLRA
GADLSLLDRLGNSVLHLAAKEGQDKILSILLKHKKAALLLDHPNGEGLNAIHVAVTSNSM
PCLLLLAAAGADVNAQERKSGRTALHLAVERDNISLAGCLLLEGDAHVDSTTYDGTTALH
IAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWEKDGEDEGVVPGTTPLDMATNWQV
FDILNGKPYEPEFTSDDLLAQGDMKQLTEDAKLQLYKLLEIPDPDKNWATLAQKLGLGIL
NNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAAFCAPGTAAPGPGK
VAPQTLSLPLSPASTRSPVGKGRTEPAPEVTSCSSGCVSASWAVAVLPTIVPCPVCLSPL
QLTGAPLCASPDAASQVGYSPQEQSH
NT seq
2961 nt
NT seq
+upstream
nt +downstream
nt
atggcagaagacgatacatatttgggagggcatgaacaaatgtttcatttggatcctttg
actcatacaatatttaacccagagttatttcaaccagagatgccactacctacagatggt
ccataccttcaaatattagagcaacctaaacagagaggatttcgtttccgttatgtatgt
gaaggcccatcccatgggggactccccggtgcatctagtgaaaagaacaagaagtcctac
cctcaggtcaaaatctgcaactatgtgggacctgcaaaggttattgttcagttggtcaca
aatgggaaaaacatccacctgcatgcacacagcctggtgggaaaacactgtgaggatggg
atctgcactgtaactgctggacccaaggacatggtggtcggctttgcaaacttgggtata
cttcatgtgacaaagaaaaaagtacttgaaacactggaagcacgaatgatagaggcatgt
acaaagggctacaatcccggacttttggtgcatcctgatcttgcctatttgcaagcggaa
ggcggaggagaccggcagctcacagatcgggaaaaggagatcatccaccaggcagctgtt
cagcagacaaaggagatggacctcagcgtggtgcggctcatgtttacagcttttcttcca
gatagcaccggcagcttcacgaggcgcctggaacccgtggtgtcagacgccatctatgac
agcaaagcccccaatgcgtccaacttgaaaattgtaagaatggacaggacagctggatgc
gtaactggaggggaagagatttatcttctctgtgacaaggttcagaaagatgacatccag
attcgattttatgaagaagaggaaaatggtgggatctgggaaggatttggagatttttcc
cccacagatgttcatagacaattcgccatcgtcttcaaaactccgaagtataaagatgtc
aacatcacaaaaccagcttccgtgtttgtccaacttcgaaggaaatctgatttggaaact
agcgaacccaaaccttttctctactaccctgaaatcaaagataaagaggaagtgcagagg
aaacggcagaagctcatgcctaatttctcagatagtttcggcggcgggagtggggccgga
gccggtggtggaggcatgtttggcagtggcggtggaggaggggctgccggaagtacgggg
ccagggtacagcttccctcactatggatttcctacatacggtggaattaccttccatcct
ggaaccactaaatctaatgccgggatgaaacacggaacaatagacaccccatctaaaaat
gattctgaaggttgtggaaagagtgtggacagagaggcagccagcctccctgggaaagta
actgaacctgcagaacaagataaggagtccagcactggggatgatgaggttactctgacg
tatacagtgggagtaaaggaagagaactctaggtttcaggacaacctctttctagagaag
gctatgcagctggccaagcggcatgccaacgccctttttgactacgcggtgacaggagat
gtgaagatgctgctggctgtccagcgccacctcactgcagtgcaggatgagaatggggac
agtgtcttacacttagcaatcatccatcttcatgctcagcttgtgagggatctactagaa
gtcacatctggtttgatttctgatgacattatcaatatgagaaatgatctctaccagaca
cccttgcacctggcagtgatcaccaagcaggaggctgtggtggaggacttgctgcgggct
ggggccgacctgagccttctggaccgcttgggtaactctgttttgcacctagctgccaaa
gaaggacaagataaaattctcagtattttactcaagcacaagaaggcagcactactgctg
gaccaccctaatggggaaggtctaaacgccattcacgtagccgtgacgagcaacagcatg
ccgtgcctgctgctgctggcggccgccggcgccgacgtcaacgcgcaggagcggaagtcc
gggcgcacggcgctgcacctggccgtggagcgcgacaacatctcgctggcgggctgcctg
ctcctggagggtgatgcccatgtagacagtaccacctatgatgggactacagccctgcac
atagcagccgggagagggtccaccaggctggcagctcttctcaaagcagcaggtgcagat
cccctggtggagaactttgagcctctctatgacctggatgactcttgggaaaaagatgga
gaggatgaaggagtcgtgcctggaaccacacctctagatatggccaccaactggcaggtg
tttgatatattaaatgggaaaccatatgagccagagtttacatctgatgatttacttgca
caaggagacatgaaacagctgactgaggatgcaaagctgcagctctacaagttgctagaa
atccctgatccagacaagaactgggcaactctggcacagaaactaggtctgggtatacta
aataatgccttccggctgagtcctgctccttctaaaactcttatggacaactatgaggtc
tccgggggtaccgtaagagagctggtggaggccctgagacagatgggctacaccgaagcc
attgaagtgatccaggcggccttctgcgccccgggaaccgcggcccccggccccgggaag
gtggcgcctcagaccctctcgctgcccctctcacctgcctccacgaggtcgccagtaggt
aagggaagaacagaaccagcccctgaggtaacctcttgctcctcaggctgtgtctcggcg
tcttgggctgtggctgtcctccccaccatcgtcccctgtcccgtgtgcctgtcacccctg
cagctcacaggtgctcccctctgcgcctctcctgatgctgccagtcaggtgggctactct
ccccaggagcagtcacattga
DBGET
integrated database retrieval system